World Radiofrequency Ablation Devices Market - Opportunities and Forecasts, 2014 - 2022

  • ID: 3773627
  • Report
  • Region: Global
  • 157 pages
  • Allied Analytics LLP
1 of 4
Radiofrequency ablation (RFA) is a medical process in which a dysfunctional tissue is ablated using the heat generated by high-frequency electromagnetic waves. Advantages of using radiofrequency current for ablation are that there is no need for general anesthetics as the nerves or muscles are not directly stimulated and the treatment is very specific to the desired tissue, without causing any significant collateral damage. It is a minimally invasive procedure that is utilized in various fields of medicine such as pain management, cardiac rhythm management, oncology, and renal denervation for hypertension. RFA helps to shrink and destroy the tumor cells. In pain management, it is used to reduce pain by heat destruction of nerves that conduct nerve impulses.

The world radiofrequency ablation devices market was valued at $1,729.7 million in 2015 and shall grow at a CAGR of 11.8% to reach $3,785.3 million by 2022. This is attributed to the increase in demand for minimally invasive surgeries, rise in prevalence of cancer, high efficacy, and short duration of the procedure. The rise in the incidence of patients with chronic pain due to the increase in prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis also contributed towards the growth of the RFAD market. However, the cost associated with this technology and lack of awareness among patients hinders the market growth.

The world RFAD market is segmented into three categories: application, product type, and geography. Based on the type of application, the market is bifurcated into oncology, pain management and cardiology. Based on product type, it is divided into devices, and disposables. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the RFAD market. On August 3, 2016, Boston Scientific Corporation completed the acquisition of Cosman Medical, which helped it to improve its product portfolio of non-opioid solutions for chronic pain. On August 7, 2016, St. Jude Medical, Inc. acquired NeuroTherm, Inc., which is expected to accelerate the growth of St. Jude Medical’s business in chronic pain and strengthen its position as a global leader in developing therapies for chronic pain treatment.

KEY MARKET BENEFITS

The world radiofrequency ablation devices market report provides an extensive analysis of the current market trends and future estimations through 2014–2022.
The market scenario is comprehensively analyzed with respect to the application and product type.
Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities.
Recent developments and key manufacturers are listed to understand the competitive market scenario.
In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

KEY MARKET SEGMENTS:

The world radiofrequency ablation devices market segmentation is illustrated as follows:

By Application

Cardiology
Conventional RF Ablation Catheters
Irrigated Tip RF Ablation Catheters
Oncology
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Liver Cancer
Kidney Cancer
Spinal Metastases
Other Cancers
Pain management
Neck Pain
Shoulder Pain
Upper Back Pain
Lower Back Pain
Knee Pain
Other Pain Syndromes

By Product Type

Devices
Disposables

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Rest of LAMEA

COMPANY PROFILES:

The key players profiled in this report are listed below:
Halyard Health, Inc.
Stryker Corporation
St. Jude Medical, Inc.
Medtronic Plc
Boston Scientific Corporation
C. R. Bard, Inc.
AngioDynamics, Inc.
Hologic, Inc.
AtriCure, Inc.
Johnson & Johnson

Other players in the RFAD market include (profiles not included in the report)

Baylis Medical
Arthrex, Inc.
inomed Medizintechnik GmbH
Sutter Medizintechnik GmbH
Bramsys Indústria e Comércio Ltda
ENDO-FLEX GmbH
Epimed International
sfm medical devices GmbH
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
2.2 Market beyond: what to expect by 2027 ($million)
2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labour and Welfare (MHLW)
3.4 Reimbursement scenarios
3.5 Porter's five forces analysis
3.5.1 Low bargaining power of suppliers
3.5.2 Moderate bargaining power of buyers
3.5.3 Low threat of new entrants
3.5.4 Low threat of substitutes
3.5.5 Moderate competitive rivalry
3.6 Clinical trials
3.7 Patent analysis
3.7.1 China: Patent Analysis by Market Participants
3.7.2 The U.S.: Patent Analysis by Market Participants
3.7.3 Europe: patent analysis, by market participant
3.7.4 Canada: patent analysis, by market participant
3.7.5 Others: Patent Analysis, by Market Participant
3.8 Top player positioning, 2015
3.9 Top impacting factors
3.9.1 Drivers
3.9.1.1 Rise in the prevalence of cancer and cardiac diseases
3.9.1.2 Increase in the number of patients suffering from pain
3.9.1.3 High efficacy and short duration of the procedure
3.9.2 Restrains
3.9.2.1 High cost of treatment
3.9.2.2 Limited awareness
3.9.2.3 Availability of other treatments
3.9.3 Opportunities
3.9.3.1 Lucrative opportunities in emerging markets
3.9.3.2 Untapped RFA market opportunity
3.9.3.3 Recent advancements

CHAPTER 4 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Irrigated-tip RF ablation catheters
4.2.5 Conventional RF ablation catheters
4.3 Oncology
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Breast cancer
4.3.5 Colorectal cancer
4.3.6 Lung cancer
4.3.7 Prostate cancer
4.3.8 Liver cancer
4.3.9 Kidney cancer
4.3.10 Spinal metastases
4.3.11 Other cancers
4.4 Pain management
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Neck pain
4.4.5 Shoulder pain
4.4.6 Upper back pain
4.4.7 Lower back pain
4.4.8 Knee pain
4.4.9 Other pain syndromes

CHAPTER 5 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Disposables
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

CHAPTER 6 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size & forecast
6.2.5 Canada market size & forecast
6.2.6 Mexico market size & forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size & forecast
6.3.5 France market size & forecast
6.3.6 U.K. market size & forecast
6.3.7 Italy market size & forecast
6.3.8 Spain market size & forecast
6.3.9 Russia market size & forecast
6.3.10 Rest of Europe market size & forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan market size & forecast
6.4.5 China market size & forecast
6.4.6 Australia market size & forecast
6.4.7 India market size & forecast
6.4.8 South Korea market size & forecast
6.4.9 Taiwan market size & forecast
6.4.10 Rest of Asia Pacific market size & forecast
6.5 Latin America, Middle East, Africa (LAMEA)
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size & forecast
6.5.5 Turkey market size & forecast
6.5.6 Venezuela market size & forecast
6.5.7 Saudi Arabia market size & forecast
6.5.8 Republic of South Africa market size & forecast
6.5.9 Rest of LAMEA market size & forecast

CHAPTER 7 COMPANY PROFILES
7.1 Halyard Health, Inc.
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.2 Stryker Corporation
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.3 St. Jude Medical, Inc.
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.5 Boston Scientific Corporation
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.6 C. R. Bard, Inc.
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & developments
7.7 AngioDynamics, Inc.
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.8 Hologic, Inc.
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.9 AtriCure, Inc.
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.10 Johnson and Johnson
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key Strategic moves & developments
*Other players in the value chain include
Baylis Medical
Arthrex, Inc.
inomed Medizintechnik GmbH
Sutter Medizintechnik GmbH
Bramsys Indstria e Comrcio Ltda
ENDO-FLEX GmbH
Epimed International
sfm medical devices GmbH
*Profiles of these players are not included. The same will be included on request.
Table 1 Radiofrequency Ablation Devices Market, Moderate Growth Scenario, By Geography, 20222027 ($Million)
Table 2 Radiofrequency Ablation Devices Market, Rapid Growth Scenario, By Geography, 20222027 ($Million)
Table 3 Radiofrequency Ablation Devices Market, Diminishing Growth Scenario, By Geography, 20222027 ($Million)
Table 4 Clinical Trials, Radiofrequency Ablation Devices Market, 20132016
Table 5 Patents Registered/Approved In The U.S., Europe, And Japan (20132016)
Table 6 China: Patent Analysis By Market Participants, 20132016
Table 7 U.S.: Patent Analysis, By Market Participant, 20132016
Table 8 Europe: Patent Analysis, By Market Participant, 20132016
Table 9 Canada: Patent Analysis, By Market Participant, 20132016
Table 10 Others: Patent Analysis, By Market Participant, 20132016
Table 11 World Radiofrequency Ablation Devices Market, By Application, 20142022 ($Million)
Table 12 World Cardiology Radiofrequency Ablation Devices Market, By Type, 20142022 ($Million)
Table 13 World Cardiology Radiofrequency Ablation Devices Market, By Region, 20142022 ($Million)
Table 14 World Oncology Radiofrequency Ablation Devices Market, By Type, 20142022 ($Million)
Table 15 World Onclology Radiofrequency Ablation Devices Market, By Region, 20142022 ($Million)
Table 16 World Pain Management Radiofrequency Ablation Devices Market, By Type, 20142022 ($Million)
Table 17 World Pain Management Radiofrequency Ablation Devices Market, By Region, 20142022 ($Million)
Table 18 Key Specifications Of Disposables USed During Radiofrequency Ablation Procedure
Table 19 World Radiofrequency Ablation Devices Market, By Product Type, 20142022 ($Million)
Table 20 World Radiofrequency Ablation Market For Devices, By Region, 20142022 ($Million)
Table 21 World Radiofrequency Ablation Market For Disposables, By Region, 20142022 ($Million)
Table 22 World Radiofrequency Ablation Devices Market, By Region, 20142022 ($Million)
Table 23 North America Radiofrequency Ablation Devices Market, By Application, 20142022 ($Million)
Table 24 North America Radiofrequency Ablation Devices Market, By Country, 20142022 ($Million)
Table 25 Europe Radiofrequency Ablation Devices Market, By Application, 20142022 ($Million)
Table 26 Europe Radiofrequency Ablation Devices Market, By Country, 20142022 ($Million)
Table 27 Asia-Pacific Radiofrequency Ablation Devices Market, By Application, 20142022 ($Million)
Table 28 Asia-Pacific Radiofrequency Ablation Devices Market, By Country, 20142022 ($Million)
Table 29 Lamea Radiofrequency Ablation Devices Market, By Application, 20142022 ($Million)
Table 30 Lamea Radiofrequency Ablation Devices Market, By Country, 20142022 ($Million)
Table 31 Halyard - Company Snapshot
Table 32 Halyard - Operating Segments
Table 33 Stryker - Company Snapshot
Table 34 Stryker - Operating Segments
Table 35 St. Jude Medical - Company Snapshot
Table 36 St. Jude Medical - Operating Segments
Table 37 Medtronic - Company Snapshot
Table 38 Medtronic Operating Segments
Table 39 Boston - Company Snapshot
Table 40 Boston Operating Segments
Table 41 Bard Company Snapshot
Table 42 Bard - Operating Segments
Table 43 Angiodynamics - Company Snapshot
Table 44 Angiodynamics - Operating Segments
Table 45 Hologic - Company Snapshot
Table 46 Hologic - Operating Segments
Table 47 Atricure - Company Snapshot
Table 48 Atricure - Operating Segments
Table 49 J&J - Company Snapshot
Table 50 J&J - Operating Segments
Fig. 1 Top Investment Pockets: World Radiofrequecny Ablation Devices Market, By Application
Fig. 2 Top Winning Strategies: Percentage Distribution (20132016)
Fig. 3 Top Winning Strategies: Nature And Type
Fig. 4 Porters Five Forces Analysis
Fig. 5 Patents Registered/Approved Worldwide, 20132016
Fig. 6 China: Patent Analysis By Market Participants, 20132016
Fig. 7 U.S.: Patent Analysis, By Market Participant, 20132016
Fig. 8 Europe: Patent Analysis, By Market Participant, 20132016
Fig. 9 Canada: Patent Analysis, By Market Participant, 2013 Through 2016
Fig. 10 Others: Patent Analysis, By Market Participant, 20132016
Fig. 11 Top Player Positioning, 2015
Fig. 12 Top Impacting Factors
Fig. 13 World Radiofrequency Ablation Devices Market, By Application, 2015
Fig. 14 Irrigated-Tip Rf Ablation Catheters Market, 20142022 ($Million)
Fig. 15 Conventional Rf Ablation Catheters Market, 20142022 ($Million)
Fig. 16 Breast Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 17 Colorectal Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 18 Lung Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 19 Prostate Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 20 Liver Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 21 Kidney Cancer Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 22 Spinal Metastases Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 23 Other Cancers Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 24 Neck Pain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 25 Shoulder Pain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 26 Upper Back Pain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 27 Lower Back Pain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 28 Knee Pain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 29 Other Pain Syndromes Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 30 World Radiofrequency Ablation Devices Market, By Product Type, 2015
Fig. 31 World Radiofrequency Ablation Devices Market, By Geography, 2015
Fig. 32 North America Radiofrequency Ablation Devices Market, By Country, 2015
Fig. 33 U.S. Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 34 Canada Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 35 Mexico Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 36 Europe Radiofrequency Ablation Devices Market, By Country, 2015
Fig. 37 Germany Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 38 France Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 39 U.K. Radiofrequency Ablation Devices Market, 2015
Fig. 40 Italy Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 41 Spain Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 42 Russia Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 43 Rest Of Europe Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 44 Asia-Pacific Radiofrequency Ablation Devices Market, By Country, 2015
Fig. 45 Japan Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 46 China Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 47 Australia Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 48 India Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 49 South Korea Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 50 Taiwan Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 51 Rest Of Asia Pacific Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 52 Lamea Radiofrequency Ablation Devices Market, By Country, 2015
Fig. 53 Brazil Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 54 Turkey Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 55 Venezuela Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 56 Saudi Arabia Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 57 Republic Of South Africa Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 58 Rest Of Lamea Radiofrequency Ablation Devices Market, 20142022 ($Million)
Fig. 59 Halyard: Revenue, By Year ($Million)
Fig. 60 Halyard: Revenue, By Segment, 2015 (%)
Fig. 61 Halyard: Revenue, By Geography, 2015 (%)
Fig. 62 Stryker: Revenue, By Year ($Million)
Fig. 63 Stryker: Revenue, By Segment, 2015 (%)
Fig. 64 Stryker: Revenue, By Geography, 2015 (%)
Fig. 65 St. Jude Medical: Revenue, By Year ($Million)
Fig. 66 St. Jude Medical: Revenue, By Product, 2015 (%)
Fig. 67 St. Jude Medical: Revenue, By Geography, 2015 (%)
Fig. 68 Medtronic: Revenue, By Year ($Million)
Fig. 69 Medtronic: Revenue, By Segment, 2016 (%)
Fig. 70 Medtronic: Revenue, By Geography, 2016 (%)
Fig. 71 Boston: Revenue, By Year ($Million)
Fig. 72 Boston: Revenue, By Segment, 2015 (%)
Fig. 73 Boston: Revenue, By Geography, 2015 (%)
Fig. 74 Bard: Revenue, By Year ($Million)
Fig. 75 Bard: Revenue, By Segment, 2015 (%)
Fig. 76 Bard: Revenue, By Geography, 2015 (%)
Fig. 77 Angiodynamics: Revenue, By Year ($Million)
Fig. 78 Angiodynamics: Revenue, By Segment, 2016 (%)
Fig. 79 Angiodynamics: Revenue, By Geography, 2016 (%)
Fig. 80 Hologic: Revenue, By Year ($Million)
Fig. 81 Hologic: Revenue, By Geography (%)
Fig. 82 Hologic: Revenue, By Product (%)
Fig. 83 Atricure: Revenue, By Year ($Million)
Fig. 84 Atricure: Revenue, By Product, 2015 (%)
Fig. 85 Atricure: Revenue, By Geography, 2015 (%)
Fig. 86 J&J: Revenue, By Year ($Million)
Fig. 87 J&J: Revenue, By Segment, 2015 (%)
Fig. 88 J&J: Revenue, By Geography, 2015 (%)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Radiofrequency Ablation Devices Market Report, forecasts that the global market is expected to garner $3,785 million by 2022, registering a CAGR of 11.8% during the period 2016-2022. The disposable devices segment dominated the market in 2015 and is expected to lead throughout analysis period.

The global radiofrequency ablation devices (RFAD) market has witnessed an unprecedented growth in the past few years. The rise in the incidence of patients with chronic pain due to the increase in the prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis have contributed towards the market growth. Factors such as large undiagnosed patient population, increasing urbanization, and growing awareness about radiofrequency ablation devices in the Asia-Pacific and Latin American is expected to contribute significantly towards the market growth. The market growth is expected to mainly rely on the rising disposable income, leading to increased adoption of RFAD in the developing regions.

The cardiology application segment dominated the RFAD market due to the well-established adoption of radiofrequency devices to treat cardiac arrhythmias. RFA is one of the most widely used methods in the electrophysiology market with a success rate of over 90%, as per clinical trials. In cardiology, irrigated RF ablation catheters are projected to grow at a CAGR of 11.6% due to their wide acceptability in the treatment of atrial fibrillation.

Oncology would be the fastest growing application market owing to the increasing preference for RFAD over chemotherapy (considering its side effects) and projected to grow at a CAGR of 14.2%. Breast cancer was the leading application for the oncology radiofrequency ablation devices market; whereas, kidney cancer would be the fastest growing segment. This is due to the fact that breast cancer is the second most common type of cancer and accounted for around one-fourth share of all cancer cases in 2015.

Among product types, the disposable devices segment occupied the majority of the market share, and is expected to maintain its market position throughout the forecast period. This is owing to the fact that use of disposables helps in eliminating cross-contamination of the infectious disease. Also, the use of disposable devices eliminates capital investment, sterilization, and replacement costs.

North America is the largest market for radiofrequency ablation devices. Newest technologies having tremendous potential and precision are developed, tested, and launched in North America, thus making it a premier market for radiofrequency ablation devices. Europe was the second leading regional market with majority revenue contribution from Germany, U.K., and France.

Key Findings of the Radiofrequency Ablation Devices Market

Cardiology was the leading segment in 2015, and is expected to maintain the lead throughout the analysis period.
Disposables dominated the market with over two-thirds of the total market share in 2015.
Radiofrequency ablation devices used for oncology is estimated to be the fastest growing segments.
Radiofrequency ablation devices market in Russia is projected to grow at a high CAGR of 14.3% and would reach $23 million by 2022.
Asia-Pacific market for radiofrequency ablation devices will be the fastest growing regional market.

The key players profiled in this report include Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., and Johnson & Johnson. Other players in the RFAD market include Baylis Medical, Arthrex, Inc., inomed Medizintechnik GmbH, Sutter Medizintechnik GmbH, Bramsys Indstria e Comrcio Ltda, ENDO-FLEX GmbH, Epimed International, and sfm medical devices GmbH.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll